Pulse Biosciences, Inc.
PLSE
Kedudukan dalam Saham
#4283
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Harga Saham
$51.39
Disegerakkan terakhir: 2026-10-21
Modal Pasaran
$3.67B
Perubahan (1 hari)
1.09%
Perubahan (1 tahun)
197.94%
Negara
US
Perdagangan Pulse Biosciences, Inc. (PLSE)
Kategori
Healthcare
Bilangan saham terbitan bagi Pulse Biosciences, Inc. (PLSE)
Bilangan saham terbitan setakat October 2026: 0
Menurut laporan kewangan terkini dan harga saham Pulse Biosciences, Inc., bilangan saham terbitan semasa ialah 0. Pada akhir October 2026, syarikat mempunyai 0 saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Pulse Biosciences, Inc. (PLSE) dari 2026 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| Tidak cukup data untuk tarikh yang disediakan. | ||
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| 354.50M | - |
US
|
|
| 461.20M | - |
FR
|
|
| - | - |
JP
|
|
| 274.79M | - |
US
|
|
| - | - |
CH
|
